Inactief instrument

Andere talen CM LIFE

Aandelen

CMLT

US1258411065

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

CM Life Sciences III : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	20-12-21
Drug Firm EQRx to Make Nasdaq Debut Monday After Merger Deal With Blank Check Company	17-12-21
CM Life Sciences III : Submission of Matters to a Vote of Security Holders - Form 8-K	17-12-21
CM LIFE SCIENCES III INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	17-12-21
CM Life Sciences III Inc.(NasdaqCM:CMLT) dropped from NASDAQ Composite Index	17-12-21
EQRx, Inc. completed the acquisition of CM Life Sciences III Inc. from CMLS Holdings III LLC and others in a reverse merger transaction.	17-12-21
EQRx and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination	02-12-21
EQRx, Inc. and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination	02-12-21
EQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference	29-11-21
CM LIFE SCIENCES III INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)	23-11-21
CM LIFE SCIENCES III INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	23-11-21
EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in Middle East, Turkey and Africa	22-11-21
EQRx Launches “Remaking Medicine: On The Record” Investor Video Series	16-11-21
CM LIFE SCIENCES III INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	15-11-21
CM LIFE SCIENCES III INC. : Entry into a Material Definitive Agreement (form 8-K)	29-10-21
CM Life Sciences III : EQRx to Collaborate With England's National Health Service Over Cheaper Cancer Medicines	19-10-21
EQRx : and NHSE Sign Memorandum of Understanding to Enter into England’s First Population Health Partnership for Cancer Drugs	19-10-21
Certain Class B Common Stock of CM Life Sciences III Inc. are subject to a Lock-Up Agreement Ending on 4-OCT-2021.	04-10-21
EQRx : Appoints Kathy Giusti to Board of Directors	27-09-21
EQRx : Announces Presentation of Phase 3 Data Demonstrating a Progression-Free Survival Benefit with Sugemalimab Consolidation Therapy in Patients with Stage III NSCLC at ESMO Congress 2021	17-09-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen CM LIFE

Aandelen

CMLT

US1258411065

Andere talen

Filters